findmyKOL

Priscilla Hsue, MD

Enriched profile

Chief, Division of Cardiology, UCLA Health; Professor of Medicine, David Geffen School of Medicine at UCLA; Chizuko and Nobuyuki Kawata Chair in Cardiology (effective July 1, 2024) · UCLA Health

ORCIDNPI
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyCardiovascular DiseaseFocusDyslipidemia / Lipid Disorders+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2005–2026

Priscilla Hsue is Chief, Division of Cardiology, UCLA Health; Professor of Medicine, David Geffen School of Medicine at UCLA; Chizuko and Nobuyuki Kawata Chair in Cardiology (effective July 1, 2024) at UCLA Health. OpenAlex indexes 377 publications with 18,004 citations (h-index 66); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Priscilla Hsue, MD, is Chief, Division of Cardiology, UCLA Health. The public record shows 377 publications with 18,004 citations (h-index 66), centered on Dyslipidemia / Lipid Disorders, Heart Failure. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 9 companies, 19 NIH-funded awards (2005–2026).

  • Most recent indexed publication: 2026 · Journal of the American Heart Association
  • Top research focus: Dyslipidemia / Lipid Disorders
  • 15 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV11 trialsHIV Infections6 trialsInflammation3 trialsDyslipidemia / Lipid Disorders3 trialsDyslipidemias3 trialsAtherosclerosis2 trialsCardiovascular Diseases2 trialsVascular Diseases2 trialsHypertension1 trialPulmonary Hypertension1 trialRheumatoid Arthritis1 trialCOVID-191 trialHeart Failure1 trial

Research focus

OpenAlex concept fingerprint
Dyslipidemia / Lipid DisordersHeart Failure

Drugs & molecules

across trials, industry payments and publications
Biktarvygeneric · Bictegravir / emtricitabine / tenofovir alafenamideClinical trialsIndustry payments6PublicationsDescovygeneric · Emtricitabine / tenofovir alafenamideClinical trialsIndustry payments1PublicationsJardiancegeneric · EmpagliflozinClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trialsIndustry payments12Merck Sharp & Dohme LLCClinical trialsIndustry payments12University of California, San FranciscoClinical trials9Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
377publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

18,004citations

Total citations across indexed works.

66h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15clinical trials

Investigator role on registered studies.

View trials
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
19NIH grants · 2005–2026

Federally funded research awards.

View funding

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    88.1%
    Beta blocker19.6%
    Metoprolol Succinate100%
    Part D12 patients
    Endothelin Receptor Antagonist15.5%
    Opsumit54%Ambrisentan46%
    Part D<11 patients
  • Blood & clotting

    11.9%
    Factor Xa inhibitor11.9%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

19 NIH research awards on record, funded 20052026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/HsuePriscilla

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • ResearchGate

    researchgate.net/scientific-contributions/Priscilla-Y-Hsue-38985763

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/dom_ucla/reel/C_01v_ySen5

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com
  • X / Twitter

    x.com/DOM_UCLA/status/1768023308774375880

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • X / Twitter

    x.com/uclaCVfellows/status/1768031607527801059

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Cardiovascular Disease, American Board of Internal Medicine

    2003
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • MD

    University of California, San Francisco School of Medicine

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org

Editorial & leadership roles

journal and society appointments
  • President

    American Society for Clinical Investigation (ASCI), 2025–2026

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org
  • Fellow

    American Heart Association (FAHA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.